HomePTHS • NYSEAMERICAN
add
Pelthos Therapeutics Inc
Previous close
$26.91
Day range
$25.70 - $27.65
Year range
$8.10 - $54.29
Market cap
80.25M USD
Avg Volume
25.93K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 7.41M | — |
Operating expense | 20.31M | 1,142.78% |
Net income | -16.24M | -857.99% |
Net profit margin | -219.25 | — |
Earnings per share | -5.30 | -82.76% |
EBITDA | -15.01M | — |
Effective tax rate | 2.78% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.20M | 1,031.80% |
Total assets | 126.43M | 5,808.39% |
Total liabilities | 68.18M | 1,811.21% |
Total equity | 58.25M | — |
Shares outstanding | 3.06M | — |
Price to book | 1.43 | — |
Return on assets | -60.36% | — |
Return on capital | -133.48% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -16.24M | -857.99% |
Cash from operations | -15.26M | -8,487.18% |
Cash from investing | 2.76M | — |
Cash from financing | 26.69M | 2,846.05% |
Net change in cash | 14.19M | 1,334.60% |
Free cash flow | -22.16M | -1,414.41% |
About
Founded
2002
Website
Employees
4
